Summary: This study analyzed the performance of three different rapid antigen tests in a clinical setting, showing varying specificities and sensitivities which did not entirely meet all expectations. Therefore, careful evaluation is needed when considering their benefits for specific testing strategies and settings.

PATHOGENS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2-Evaluation of the accuracy and ease-of-use

Lisa J. Krueger et al.

Summary: The Abbott PanBio antigen-detecting rapid diagnostic test (Ag-RDT) demonstrated good performance for SARS-CoV-2 testing, with higher sensitivity observed in samples with Ct values <25 and within the first seven days of symptom onset. The test was also rated as easy to use and suitable for point-of-care settings, confirming its WHO recommendation for Emergency Use in resource-limited environments.

PLOS ONE (2021)

添加到收藏夹

False positive rapid antigen tests for SARS-CoV-2 in the real-world and their economic burden

相关参考文献

Coronavirus disease 2019 (COVID-19) vaccination in healthcare workers: An early real-world experience

Regular mass screening for SARS-CoV-2 infection in care homes already affected by COVID-19 outbreaks: Implications of false positive test results

Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected nasal swab versus professional-collected nasopharyngeal swab

Limits and Opportunities of SARS-CoV-2 Antigen Rapid Tests: An Experienced-Based Perspective

The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2-Evaluation of the accuracy and ease-of-use

导出引文

分享论文